Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Olof Gidlöf

Research project participant

Default user image.

Profiling of the plasma proteome across different stages of human heart failure

Author

  • Anna Egerstedt
  • John Berntsson
  • Maya Landenhed Smith
  • Olof Gidlöf
  • Roland Nilsson
  • Mark Benson
  • Quinn S. Wells
  • Selvi Celik
  • Carl Lejonberg
  • Laurie Farrell
  • Sumita Sinha
  • Dongxiao Shen
  • Jakob Lundgren
  • Göran Rådegran
  • Debby Ngo
  • Gunnar Engström
  • Qiong Yang
  • Thomas J. Wang
  • Robert E. Gerszten
  • J. Gustav Smith

Summary, in English

Heart failure (HF) is a major public health problem characterized by inability of the heart to maintain sufficient output of blood. The systematic characterization of circulating proteins across different stages of HF may provide pathophysiological insights and identify therapeutic targets. Here we report application of aptamer-based proteomics to identify proteins associated with prospective HF incidence in a population-based cohort, implicating modulation of immunological, complement, coagulation, natriuretic and matrix remodeling pathways up to two decades prior to overt disease onset. We observe further divergence of these proteins from the general population in advanced HF, and regression after heart transplantation. By leveraging coronary sinus samples and transcriptomic tools, we describe likely cardiac and specific cellular origins for several of the proteins, including Nt-proBNP, thrombospondin-2, interleukin-18 receptor, gelsolin, and activated C5. Our findings provide a broad perspective on both cardiac and systemic factors associated with HF development.

Department/s

  • EXODIAB: Excellence in Diabetes Research in Sweden
  • Molecular Epidemiology and Cardiology
  • Cardiovascular Research - Epidemiology
  • Artificial Intelligence in CardioThoracic Sciences (AICTS)
  • Cardiovascular Epigenetics
  • Lund Hemodynamic Lab
  • EpiHealth: Epidemiology for Health
  • WCMM-Wallenberg Centre for Molecular Medicine

Publishing year

2019

Language

English

Publication/Series

Nature Communications

Volume

10

Issue

1

Document type

Journal article

Publisher

Nature Publishing Group

Topic

  • Cardiac and Cardiovascular Systems

Status

Published

Research group

  • Molecular Epidemiology and Cardiology
  • Cardiovascular Research - Epidemiology
  • Artificial Intelligence in CardioThoracic Sciences (AICTS)
  • Cardiovascular Epigenetics
  • Lund Hemodynamic Lab

ISBN/ISSN/Other

  • ISSN: 2041-1723